Title: The EU Court of Justice clarifies the conditions under which ‘pay-for-delay' agreements preventing generic versions of a patented medicine from entering the market or delaying such entry may constitute a restriction of competition ‘by object' or ‘by effect” as well as an abuse of dominant position (Generics - UK)
Abstract: On 30 January 2020, the Court of Justice of the EU (‘CJEU') ruled on the applicability of competition law to settlement agreements between a holder of a pharmaceutical patent and manufacturers of…
Publication Year: 2020
Publication Date: 2020-01-30
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot